Skip to content

4Accepted Sep 3, 4:09 PM ET

Ascendis Pharma (ASND) Director Lars Holtug Sells Shares

ASNDAscendis Pharma A/S

Accepted (ET)

4:09 PM

Sep 3, 2026

Filed

Sep 3, 2026

Documents

1

Size

4.6 KB

Summary

Ascendis Pharma (ASND) Director Lars Holtug Sells Shares

Updated

What Happened Lars Holtug, a director of Ascendis Pharma A/S (ASND), reported a sale of 236 shares on 2026-09-02 at $264.13 per share, for a total value of approximately $62,335. The Form 4 reporting this transaction was filed on 2026-09-03.

Key Details

  • Transaction date: 2026-09-02; Form 4 filed: 2026-09-03 (appears timely).
  • Price and size: 236 shares sold at $264.13 each; total ≈ $62,335.
  • Transaction type: Reported as an open market or private sale (code S).
  • Shares owned after the transaction: Not specified in the information provided on the filing.
  • Footnotes / trading plan: No 10b5-1 plan, tax withholding, or other footnotes were indicated in the reported details provided.

Context Insider sales are common and can reflect routine diversification, liquidity needs, or other personal reasons; they do not by themselves indicate management’s view of the company’s prospects. Purchases are generally more informative about insider confidence than occasional sales.

AI-written summary · check the filing